International Isotopes INC Form 4 insider transactions

Radnostix Inc. reports a $500,000 convertible promissory note with Kershner, Grosso & Co., convertible into common stock at $0.07 per share.

Director Christopher G. Grosso acquired 581,536 shares of Radnostix Inc. common stock as a dividend payment on preferred holdings.

International Isotopes Inc. Director Robert Atcher received a grant of 250,000 restricted stock units, increasing his total beneficial ownership to 1,000,000 shares.

International Isotopes Inc. Director Steve Laflin acquired 500,000 stock options with an exercise price of $0.06 per share under a Rule 10b5-1 plan.

International Isotopes Inc. Director and 10% owner Christopher G. Grosso acquired 500,000 stock options with an exercise price of $0.06.

International Isotopes Inc. CEO Shahe Bagerdjian was granted 37.5 million restricted stock units, vesting upon achievement of specific share price and cash metrics.

International Isotopes Inc.'s President and CEO, Shahe Bagerdjian, purchased 140,000 shares of common stock at $0.05 per share, increasing his direct beneficial ownership to over 9 million shares.

Director Christopher G. Grosso receives stock options for 1,500,000 shares of International Isotopes Inc.

Director Christopher G. Grosso reports acquisition of International Isotopes Inc. shares in lieu of cash dividends on Series C Preferred Stock.

Shahe Bagerdjian, President and CEO of International Isotopes Inc., reports the disposal of 583,229 shares of common stock to cover tax obligations upon vesting of a restricted stock unit award.

Shahe Bagerdjian, President and CEO of International Isotopes Inc., purchased 177,000 shares of common stock at $0.05 per share on March 6, 2025.

International Isotopes Inc.'s President and CEO, Shahe Bagerdjian, purchased 100,000 shares of common stock at $0.04 per share.

International Isotopes Inc.'s Chief Financial Officer, W Matthew Cox, has increased his holdings in the company through recent open market purchases of common stock.

A director of International Isotopes Inc. has significantly increased their stake in the company through a recent share purchase.

Director Christopher G. Grosso increased his holdings in International Isotopes Inc. (INIS) through recent purchases of common stock.

Shahe Bagerdjian, President and CEO of International Isotopes Inc., acquired 350,000 shares of common stock on September 13, 2024, through the grant of restricted stock units.

Shahe Bagerdjian, President and CEO of International Isotopes Inc., reports the disposition and acquisition of company stock.

W Matthew Cox, CFO of International Isotopes Inc., reports the acquisition of 239,669 shares of common stock at $0.04 per share.

Robert Atcher, a director at International Isotopes Inc., acquired 750,000 shares of common stock on March 3, 2023, through restricted stock units (RSUs) granted under the company's incentive plan.